Phase 3 Diabetes Type 2 Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)
ObesityOverweightType 2 Diabetes+2 more
Pfizer999 enrolled183 locationsNCT07400653
Recruiting
Phase 2Phase 3
Canagliflozin Targeting Vascular Inflammation
Coronary Artery DiseaseDiabetes Type 2
Ottawa Heart Institute Research Corporation24 enrolled1 locationNCT05427084
Not Yet Recruiting
Phase 3
The FAME 2 Kidney trial is a study of whether fenofibrate is able to slow kidney disease progression in adults with type 2 diabetes with moderate kidney damage
Diabetes Type 2
Baker Heart & Diabetes Research Insitute1,000 enrolled4 locationsACTRN12625001170415